Clinical Trials Directory

Trials / Unknown

UnknownNCT04142840

Dexmedetomidine and Propofol in the Treatment of Emergence Agitation

Comparing the Efficacy of Dexmedetomidine and Propofol in the Treatment of Emergence Agitation Occurring in Adults After General Anesthesia: A Randomised Control Trial DP-TEA Trial

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

1. This clinical research aims to compare the effects of dexmedetomidine and propofol on the treatment of emergence agitation in adult patients after general anesthesia. 2. Half of participants will receive dexmedetomidine while the other half will receive propofol when emergence agitation happens.

Detailed description

As a common problem observed in pediatric patients after sevoflurane anesthesia, emergence agitations are investigated mainly in children.For adults,previous studies were almost about the efficacy of premedication on preventing emergence agitation. Once emergence agitation happens, there is still no guidelines established to recommend the medication usage in the post-anaesthesia care unit.So high-quality prospective clinical studies are required to provide evidence for emergence agitation treatment. Dexmedetomidine and propofol are both widely used in general anesthesia and can be acquired easily.When emergence agitation occurs,both injections are common choices in daily clinical administration on emergence agitation.To the investigator's knowledge ,propofol with a very quick onset is superior for anesthesia goals, but is without analgesia effects.While dexmedetomidine can produce sedation,analgesia,anxiolysis.So the investigators propose the hypothesis here that dexmedetomidine is prior to propofol on the treatment of emergence agitation in adults patients after general anesthesia.Therefore this research is undertaken to verify the hypothesis.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinea selective α-2 adrenoceptor agonist which is widely used as an adjuvant to general anesthesia
DRUGPropofola short -acting medication that result in a decreased level of consciousness and lack of memory for events,widely used including the starting and maintenance of general anesthesia.

Timeline

Start date
2019-11-01
Primary completion
2021-08-30
Completion
2021-08-30
First posted
2019-10-29
Last updated
2020-01-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04142840. Inclusion in this directory is not an endorsement.